Aspire Biopharma Holdings (ASBP) EPS (Diluted) (2021 - 2026)
Aspire Biopharma Holdings (ASBP) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 0.15 |
| 10 | Aspire Biopharma Holdings | 8.34 Mn | -3.83 Mn | -30,086.00 | -1.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.22 |
| Mar 31, 2026 | -20.57 |
| Dec 31, 2025 | -162.20 |
| Sep 30, 2025 | -63.62 |
| Mar 31, 2025 | -504.87 |
| Dec 31, 2024 | -1.41 |
| Sep 30, 2024 | -33.42 |
| Jun 30, 2024 | -85.37 |
| Mar 31, 2024 | -329.25 |
| Dec 31, 2023 | -7.95 |
| Sep 30, 2023 | -9.24 |
| Jun 30, 2023 | 110.76 |
| Mar 31, 2023 | 23.98 |
| Dec 31, 2022 | -4.34 |
| Sep 30, 2022 | 35.97 |
| Jun 30, 2022 | 1.01 |
| Mar 31, 2022 | -4.38 |
| Dec 31, 2021 | -0.14 |
| Sep 30, 2021 | -2.94 |
| Mar 31, 2021 | -2.70 |